HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea T Hooper Selected Research

Differentiation Antigens

9/2008Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea T Hooper Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 05/2002
10COVID-19
10/2022 - 01/2021
3Asymptomatic Infections
01/2022 - 01/2021
3Breast Neoplasms (Breast Cancer)
10/2006 - 12/2003
2Infections
06/2021 - 01/2021
2Carcinoma (Carcinomatosis)
04/2010 - 05/2002
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
03/2010 - 09/2009
2Neoplasm Metastasis (Metastasis)
09/2008 - 06/2002
2Adenocarcinoma
06/2008 - 08/2004
1Hypophosphatemia
01/2022
1Hypersensitivity (Allergy)
01/2021
1Colonic Neoplasms (Colon Cancer)
01/2020
1Myocarditis (Carditis)
01/2019
1Diabetes Mellitus
01/2013
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2010
1Cystitis
04/2010
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2010
1Cytopenia
09/2009
1Vascular Remodeling
07/2009
1Melanoma (Melanoma, Malignant)
09/2008
1Carcinogenesis
06/2008
1Inflammation (Inflammations)
06/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2007
1Sarcoma (Soft Tissue Sarcoma)
03/2007
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2006
1Hyperplasia
10/2006
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2006
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2006
1Lymphoma (Lymphomas)
10/2006
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2006
1Hypopigmentation (Hypomelanosis)
02/2006
1Neutropenia
07/2005
1Multiple Myeloma
04/2005

Drug/Important Bio-Agent (IBA)

10Monoclonal AntibodiesIBA
10/2022 - 05/2002
9casirivimab and imdevimab drug combinationIBA
10/2022 - 01/2021
6Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2007
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2009 - 06/2002
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2008 - 06/2002
4Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2008 - 06/2002
4LigandsIBA
03/2007 - 12/2003
3Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2006 - 04/2005
2Cadherins (E-Cadherin)IBA
01/2022 - 01/2018
2PF-06671008IBA
01/2022 - 01/2018
2Immunoconjugates (Immunoconjugate)IBA
01/2022 - 08/2011
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2021 - 03/2007
2Immune Checkpoint InhibitorsIBA
01/2020 - 01/2019
2Antineoplastic Agents (Antineoplastics)IBA
08/2011 - 03/2007
2CytokinesIBA
03/2010 - 12/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2007 - 06/2002
2Mitogen-Activated Protein KinasesIBA
10/2006 - 12/2003
2DNA (Deoxyribonucleic Acid)IBA
02/2006 - 08/2004
1COVID-19 VaccinesIBA
10/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Extracellular Matrix ProteinsIBA
01/2022
1Cell Adhesion MoleculesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Fibronectins (Fibronectin)IBA
01/2022
1auristatinIBA
01/2022
1Histones (Histone)IBA
01/2022
1Immunoglobulin A (IgA)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
09/2021
1Neutralizing AntibodiesIBA
01/2021
1CD3 ComplexIBA
01/2018
1Metformin (Glucophage)FDA LinkGeneric
02/2014
1Adenosine Triphosphate (ATP)IBA
02/2014
1Glucose (Dextrose)FDA LinkGeneric
02/2014
1Glutathione (Reduced Glutathione)IBA
02/2014
1NADP (NADPH)IBA
02/2014
1Lactic Acid (Lactate)FDA LinkGeneric
02/2014
1Monocarboxylic Acid TransportersIBA
02/2014
1erucylphosphocholineIBA
01/2013
1CEACAM1 ProteinIBA
04/2010
1ImmunosorbentsIBA
04/2010
1EnzymesIBA
04/2010
1N 30IBA
04/2010
1human FLT4 proteinIBA
09/2009
1Carrier Proteins (Binding Protein)IBA
07/2009
1tumor-derived adhesion factorIBA
07/2009
1Differentiation AntigensIBA
09/2008
1DC101 monoclonal antibodyIBA
09/2008
1Epithelial Cell Adhesion MoleculeIBA
06/2008
1Interleukin-10 (Interleukin 10)IBA
06/2008
1CaspasesIBA
02/2008
1macrophage stimulating proteinIBA
03/2007
1Messenger RNA (mRNA)IBA
03/2007
1Small Interfering RNA (siRNA)IBA
03/2007
1AngiopoietinsIBA
03/2007
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
04/2005
1Interleukin-12 (IL 12)IBA
08/2004
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2003
1Cell Surface ReceptorsIBA
12/2003
1Insulin-Like PeptidesIBA
12/2003

Therapy/Procedure

9Therapeutics
01/2022 - 05/2002
2Drug Therapy (Chemotherapy)
08/2011 - 07/2005
1Subcutaneous Injections
01/2021
1Transplantation
03/2010
1Immunotherapy
09/2008
1Heterologous Transplantation (Xenotransplantation)
06/2008